WO2010029479A1

WO2010029479A1 - Therapy system for depositing energy

Info

Publication number: WO2010029479A1
Application number: PCT/IB2009/053869
Authority: WO
Inventors: Max O. KÖHLER; Teuvo J. Vaara; Shunmugavelu Sokka; Gosta J. Ehnholm
Original assignee: Koninklijke Philips Electronics N.V.
Priority date: 2008-09-09
Filing date: 2009-09-04
Publication date: 2010-03-18
Also published as: JP5887137B2; JP2013503653A; US20110313329A1; US9669240B2; CN102149431B; EP2334376A1; RU2011113751A; EP2334376B1; CN102149431A; RU2518528C2

Abstract

A therapy system comprises a therapy module to perform successive deposits of energy in a target zone, the therapy system being provided with a control module is configured to prior the deposits of energy produce an a priori estimate of the induced heating. For example a thermometry module is provided to measure temperature in a measurement field. The induced heating may be derived on the basis of a tissue model from the settings of the therapy module. In particular the therapy module is a high- intensity focuses ultrasound transmitter. A magnetic resonance examination system configured for thermometry is employed as the thermometry module.

Description

Therapy system for depositing energy

BACKGROUND OF THE INVENTION

The invention pertains to a therapy system to deposit energy into a target zone.

Such a therapy system is known from the paper 'Determination of the optimal delay between sonications during focused ultrasound surgery in rabbits by using MR imaging to monitor thermal build-up in vivo' by N.J.McDannold et al. in Radiology 211 (1999)419- 426.

In this document an in vivo sonication experiment is mentioned in which a system for monitoring ablation of tissue is investigated. This known system monitors the ablation process in that heat damage to tissue in monitored. The known system for monitoring ablation performs monitoring e.g. on the basis of magnetic resonance images. Moreover, the cited document mentions that energy can be delivered as sonications in the form of focused ultrasound waves. Further it is mentioned that closely spaced sonications are delivered that are spaced by an intersonication delay to minimize thermal build-up. That is successive deposits of energy are separated in time by a cool-down period. To minimize this intersonication delay the temperature build-up should be measured during treatment. This temperature information is then used to control the intersonication delay.

The cool down period between successive deposits of energy allows temperature to reduce in a region around the focal region into which the energy is directly deposited. Thus, temperature build-up in the region around the focal region, i.e. the so-called off- focus temperature build-up, is reduced. Thus, the risk is reduced for thermal damage to healthy tissue outside of the focal region.

The known therapy system is provided with a thermometry module in the form of am MR imager to measure the temperature in a measurement field. Generally, the measurement field contains the focal region into which the energy is directly deposited. The duration of the cool down period between the successive deposits of energy is controlled on the basis of the measured temperature. In this way it is avoided that the time required for the successive deposits of energy is longer than necessary, while off- focus temperature build-up is avoided. SUMMARY OF THE INVENTION

An object of the invention is to provide a therapy system which is able to more accurately apply energy into the target zone, in particular to more accurately set the cool down period. This object is achieved by a therapy system according to the invention comprising a therapy module to perform successive deposits of energy in a target zone, and a control module to regulate the therapy module and - wherein the control module is configured to prior the deposits of energy produce an a priori estimate of the induced heating.

According to the invention, the induced heating is formed before activation of the therapy module, so that it may be established whether activation of the therapy module is safe. Notably, the safety of each energy deposit is estimated a priori when the amount of energy to be deposited and position have been determined. The induced heating can be estimated on the basis of the parameter settings of the therapy module and a tissue model or the induced heating can be estimated from temperature measurements of the target area. The energy is directly deposited in the so-called focal area. If the estimated induced heating around the focal region, i.e. the so-called off-focus area, with the desired therapy parameters is found excessive by some predefined measure then therapy of this planned energy deposit is inhibited, and required to be re-planned till estimated off- focus heating is acceptable. The risk of performing unsafe energy deposits is thus reduced by first estimating the induced heating by the planned energy deposit. Also, the risk of off- focus temperature build-up is estimated more accurately because account is taken of the transport of heat from the target zone into the surrounding region. The induced off- focus heating is equivalent to temperature build-up in the off- focus heating. Thus, the risk of performing unsafe energy deposits is reduced. This a priori estimate is accurately set for the particular target zone and its surroundings.

These and other aspects of the invention will be further elaborated with reference to the embodiments defined in the dependent Claims.

According to an aspect of the invention an a priori estimate of the cool down period is made prior to the energy deposits. In particular the cool down period is estimated on the basis of the estimated induced heating by a subsequent energy deposit. As an alternative the induced heating is estimated on the basis of a measurement e.g. by MR thermometry or MR thermography. The first cool down period between the first energy deposits is already accurate. Moreover, only relatively minor adjustments of the cool down period between subsequent energy deposits are needed. Because the duration of the cool-down period is more accurately set, the next energy deposit can be initiated as soon as the temperature has decreased sufficiently, thereby leaving the risk of off- focus temperature build-up low. The a priori estimate of the induced heating may be refined based on the measured thermal behavior. Thus, the duration of the cool-down period is accurately set already for the first energy deposits so that the next energy deposit is made just after the risk of off- focus temperature build-up is sufficiently low. Alternatively, the a priori estimate for the cool down period can be made on the basis of temperature measurements of the target zone and its surroundings prior to the energy deposits. These measurements may also be employed to accurately set parameters for the tissue model for the individual patient to be treated and the particular part of the anatomy in which the target zone is located.

In particular when MR thermometry is employed, a relative measurement of temperature of notably the target zone as well as off- focus region is obtained. That is, temperature is accurately obtained relative to a baseline value at the start of an individual energy deposition. As the cool down period between successive energy depositions has been accurately set already from the first energy deposition, reliable equal baseline temperatures apply for subsequent energy depositions. According to a further aspect of the invention the a priori estimate for the induced heating, off- focus and/or in the target region, and or the cool down period are made on the basis of a thermal tissue model. The thermal tissue model represents the thermal perfusion and diffusion, i.e. the transport of heat through the tissue. The thermal tissue model used for simulation can be based on the Pennes' bioheat equation or other similar models, that all require the intensity distribution as input in addition to other thermal parameters. The intensity distribution may in turn be calculated based on a multilayer tissue model using for example a ray-tracing or Waveller algorithm, or in a more simplified approach a Raleigh integral. The layered tissue model may in turn be acquired based on segmented treatment planning images. The acoustic and thermal parameters may be determined for each layer either based on prior knowledge and/or refined based on seen heating thereby improving the accuracy of the estimates even further. The simulations may also be beneficially utilized to estimate the focal region heating before initiating the heat deposition.

According to a further aspect of the invention thermo-acoustic simulations utilizing the specific 3D geometry of the tissue can improve the accuracy of the off-focus maximum temperature estimate prior to start of the energy deposit. The 3D geometry is used in that heat transfer both along and transverse to the energy deposition is taken into account. Notably, when focused ultrasound is used, the thermal tissue model accounts for heat transfer along and transverse to the ultrasound beam path. Further, temperature is measured e.g. within several slices in and next to the target zone. In practice good results have been obtained when six (6) slices are employed. Such simulations could be performed before each planned energy deposit, thereby improving treatment safety and efficiency further. In particular thermo-acoustic simulations utilizing the specific 3D geometry of the tissue can improve the accuracy of the cool-down estimate provided by the thermal tissue model. Such simulations could be performed before each planned energy deposit or after the seen heating during cool-down to further improve the accuracy of the cool-down estimate, thereby improving treatment safety and efficiency further.

According to another aspect of the invention, the control module compares the estimated induced heating to a safety limit. If a priori estimated induced heating for the upcoming planned energy deposit creates an unacceptable risk to the patient then the control module inhibits the therapy module to be activated at the setting that corresponds to the estimated induced heating. The induced heating can be represented e.g. by the estimated maximum temperature and/or thermal dose. The safety limit is preset based on previous experiments or on the basis of model calculations. The value of the safety limit can be dependent on properties of the patient to be treated, such as age, physical condition, gender etc.

According to another aspect of the invention the cool-down period is set on the basis of the maximum temperature in the preceding energy deposit. This involves a relatively simple measurement of the maximum temperature. One of the insights of the invention is that the temperature build-up of tissue outside of the focal region is dependent on the deposited energy density. Notably this is the case for energy deposition in the form of a focused ultrasound beam. The deposited energy density at any given position can be accurately calculated on the basis of the parameters of the heat deposit. In particular the deposited energy density deposited by a (e.g. focused ultrasound) beam is accurately computed on the basis of the beam power, propagation direction of the beam, depth from the skin to the target zone and further geometry of the beam. Further, a refined estimate of the deposited energy density is obtained when taking into account absorption and deflection of the energy beam. The energy density can be used to estimate the maximum temperature in the off- focus region. The maximum temperature in the off- focus region is approximately linearly dependent on the deposited energy density, i.e. the ultrasound energy density deposited in the off- focus region. The off- focus region is formed by a cross-section transverse to the beam-path. The linear dependence appears to be valid when temperature decrease due to diffusion of heat can be neglected in the middle of the off- focus ultrasound cone during heating. This maximum temperature estimate, based on the energy density, can in itself be used to reduce the risk of inducing excessive heating in undesired off- focus areas.

According to a further aspect of the invention a comparatively simple approximation of the duration of the cool-down period is proportional to the square of the maximum temperature the off- focus region reached in the preceding energy deposit. This dependency of the cool-down period on maximum temperature holds very well for when the cross-section of the beam-path of the energy deposit is circular (as for example if the beam- path has the shape of a cone). In other cases, the square relationship would be distorted slightly, but the exact relationship can be recalculated for any beam-path cross-section. In a particular embodiment of the invention, the therapy module is a high- intensity focused ultrasound emitter. In this embodiment the energy deposit is carried-out by irradiating the target zone with a high-intensity focused ultrasound (HIFU) beam, often indicated as 'sonication'. The HIFU-beam causes local heating of the tissue mainly in the focal region which causes thermal ablation in the focal region. Also slight heating of other regions within the HIFU beam occurs. In another embodiment of the invention, the therapy module is a micro-wave emitter. In this embodiment the energy deposit is carried-out by irradiating the target zone with microwave irradiation. The microwave radiation causes local heating of the tissue which causes thermal ablation in the focal region, while also heating tissues in off- focus areas slightly. In another embodiment of the invention, the therapy module is an RF-antenna.

In this embodiment the energy is deposited via heat-conduction from the antenna placed in contact with the target zone. The RF-heating causes a local temperature increase which causes thermal ablation around the antenna, and by changing the energy density dependency on the maximum temperature rise all of the aspects outlined above may be employed. In another embodiment of the invention, the monitoring module may rely on

MRI, ultrasound or CT images for therapy monitoring. Any other temperature sensitive imaging modality may also be used.

The invention further relates to a computer program as defined in Claims 11 and 12. The computer program of the invention can be provided on a data carrier such as a CD-rom disk or a USB memory stick, or the computer program of the invention can be downloaded from a data network such as the world-wide web. When installed in the computer included in a therapy system the therapy system is enabled to operate according to the invention and achieve higher safety of use and more accurate setting of the cool down period.

These and other aspects of the invention will be elucidated with reference to the embodiments described hereinafter and with reference to the accompanying drawing wherein

DESCRIPTION OF THE DRAWINGS

Figure 1 shows a diagrammatic representation of the therapy system in which the invention is employed,

Figure 2 shows an example of the cool-down time.

DETAILED DESCRIPTION OF THE EMBODIMENTS

Figure 1 shows a diagrammatic representation of the therapy system in which the invention is employed. The therapy unit 1 , for example in the form of a high- intensity focused ultrasound (HIFU) unit generates a therapeutic action in the form of a focused ultrasound beam 11. The focused ultrasound beam 11 is accurately directed onto a target zone 2 that includes the actual target 3. For example the target is a tumor in (part of) an organ 2 of the patient to be treated. The HIFU unit 1 is operated so that the focused ultrasound beam 11 moves over the volume of the target zone 2. The ultrasound beam 11 deposits energy in the target zone, causing elevated temperature especially in the tumor. In this way desired parts of the tissue is raised to a level where necrosis of the tissue occurs. Ultimately necrosis occurs in the tissue of the tumor and around it in the target zone once the desired thermal dose or temperature is reached. In particular the thermal dose can be calculated in a

simple approximation as ° , where r=0.25 when T<43°C and r=0.5 when

T>=43°C. A dose limit of 240 equivalent minutes at 43⁰C is typically thought to result in necrosis. A modified version of the equation exists that takes the effect of uncertainty into account. In this scope one or several limits (or potentially a lower one) can be checked to ensure that once reached, deposition of energy is stopped. Following temperature only, tells us that necrosis will most probably occur, whereas thermal dose ensures us of it. For example, necrosis is achieved when the intensity at the focus of the focused ultrasound beam is about lβOOWcm^"2 for a duration of the order of tens of seconds. At this maximum energy level efficient necrosis is achieved without the risk of cavitation. The ultrasound beam can also be used to elevate tissue temperatures to non-necrosis temperature levels. These lower temperatures are useful in hyperthermia type applications.

The temperature distribution of the measurement field is derived from magnetic resonance signals. To this end the patient is placed in a magnetic resonance examination system (not shown) and magnetic resonance signals 22 are generated. The magnetic resonance signals are received by the MR signal acquisition system 21 that is part of the magnetic resonance examination system. The MR signal acquisition system includes RF receiving antennae (coils) and a signal processing system, such as a spectrometer. The acquired magnetic resonance signals are applied to the thermometry module 4 which derives the temperature distribution in the target zone. The phase of the magnetic resonance signals, but also other parameters, depends on temperature. The magnetic resonance signals are spatially encoded by means of encoding magnetic gradient fields, such as read and phase encoding gradients. The spatial resolution of the magnetic resonance signals and the ensuing temperature distribution is at the scale of a millimeter; even sub-millimeter resolution can be obtained where the smallest detail that can de distinguished has a size of a few tenths of a millimeter. For example if there are several slices in the stack monitoring the temperature, then the measurement field used can advantageously be projected to all parallel slices in the focal-region even though the focal-point trajectory is only in the middle slice of the stack. Because the widest and hottest plane of the typically ellipsoidal heated region may wander towards the transducer during heating, this reduces the risk of the treated region having a larger radius than desired measured from the beam-axis. A measurement field along the beam-axis can also be applied to control that the 240EM dose length does not exceed a maximum length if we have a sagittal plane (which we do). This improves safety considerably.

Off-focus slices (e.g. two of them) can also be added at regions of particular interest, e.g. tissue interfaces where acoustic impedance changes significantly as such regions are prone to off- focus heating. These can be used to automatically detect excessive heating and/or thermal dose in these off- focus areas of interest for any single energy deposit and excessive cumulative heating and/or thermal dose for the entire treatment. Accurate results in moving tissue are obtained when a motion correction is applied and phase contribution due to motion are separated from phase contributions due to temperature changes. The motion correction can be derived from the magnetic resonance signals, notably by redundant magnetic resonance signals from the central portion of k-space. A motion compensation module 23 is provided to derive the motion correction and apply motion compensation to the magnetic resonance signals. The motion corrected magnetic resonance signals are applied to the thermometry module 4 which derives local temperature distribution of the target zone 3. Alternatively, the motion compensation module 23 can be configured or programmed in software to derive separate the contribution to the phase of magnetic resonance signals due to motion and compute the contribution of the phase due to temperature changes. The local temperature distribution is applied to the control module 5, which controls the therapy module, i.e. the HIFU unit 1 to focus the focused ultrasound beam along a next trajectory. The centre of concentricity can for example be continuously evaluated (e.g. by Gaussian fits or weighted average) to take into account the possibility of the treated (notably heated) region shifting slightly (typically l-2voxels or 0.5 -5mm) during treatment due to e.g. spasms or slightly non-uniform heat diffusion.

The therapy system of the invention is provided with a delay module 6 which delays the activation of the therapy module 1. The delay leads to the cool-down period. The delay is set by the control unit on the basis of the measured temperature. The delay unit may be configured to trigger the therapy module. In another embodiment the therapy module is configured to apply regular deposits of energy, e.g. apply regular ultrasound pulses (i.e. sonications). In this embodiment the delay module is configured to interrupt the therapy module. In practice a number of sonications is interrupted or cancelled so as to cause the cool-down period.

Figure 2 shows an example of the cool-down time to reach within 3 ⁰C of the starting temperature as a function of the maximum near- field temperature. The fit is a square, i.e. quadratic function of the maximum temperature fitted through 3⁰C and the R value is 0.90. In these cases the temperature was filtered with a 5 x 5 voxel median filter (voxel size 2.5 x 2.5 mm²). Notably, spatial filtering of the measured temperature, e.g. by way of a median filter, improves the signal — to-noise ratio of the temperature measurement. The loss of spatial resolution does not lead to problems since the off- focus heating typically is void of sharp spatial gradients. This data was acquired for a HIFU-therapy module with a circular beam-path cross-section. The fit to 3⁰C may be changed to any desired predefined baseline temperature level.

Claims

CLAIMS:

1. A therapy system comprising a therapy module to perform successive deposits of energy in a target zone, the therapy system being provided with a thermometry module to measure temperature in a measurement field and a control module to regulate the therapy module and wherein the control module is configured to prior the deposits of energy produce an a priori estimate of the induced heating.

2. A therapy system, in particular as claimed in Claim 1, the successive deposits being separated by a cool down period, wherein the control module is configured to regulate the cool down period and prior the deposits of energy produce an a priori estimate of the cool down period, on the basis of the estimated induced heating.

3. A therapy system as claimed in Claim 1 further comprising a thermometry module to measure temperature in a measurement field and the control module being arranged to estimate induced heating on the basis of the measured temperature.

4. A therapy system as claimed in Claim 1, wherein the control module is configured to estimate the induced heating on the basis of a thermo-acoustic layered tissue model.

5. A therapy system as claimed in Claim 2, wherein the thermo-acoustic layered thermal tissue model accounts for heat distribution both along and transverse to the direction of the energy deposition.

6. A therapy system as claimed in Claim 1, wherein the control module is configured to estimate the off- focus heating based on the local deposited energy density.

7. A therapy system as claimed in Claim 1, wherein the control module is configured to compare the estimated induced heating to a safety value and inhibit a next energy deposit when the estimated induced heating exceeds the safety value.

8. A therapy system as claimed in Claim 1, wherein the control module is configured to estimate the cool-down period on the basis of a measured temperature caused by the previous energy deposits.

9. A therapy system as claimed in Claim 3, wherein the control module is configured to regulate the cool down period on the basis of the thermo-acoustic layered tissue model.

10. A therapy system as claimed in Claim 1, wherein the control module is arranged to regulate the cool down period in dependence of the measured maximum temperature during the energy deposit preceding the cool down period.

11. A therapy system as claimed in Claim 1 , wherein the control module is configured to regulate the spatial deposition of heat in dependence of the temperature measured and/or estimated during the previous heating and cool-down period and/or recommend position for next heat deposit to reduce risk of off- focus overlap and thus heat build-up, based on temperature measured and/or estimated during the previous heating and cool-down period

12. A therapy system as claimed in Claim 1, wherein the therapy module is a high- intensity ultrasound emitter, a micro-wave emitter or and RF antenna.

13. A computer program including instructions to prior the deposits of energy produce an a priori estimate of induced heating and regulate a therapy module on the basis of the a priori estimate.

14. A computer program e as claimed in Claim 11, further including instructions to perform successive deposits of energy in a target zone, the successive deposits being separated by a cool down period separate the successive deposits by a cool down period, measure temperature in a measurement field and regulate the cool down period in dependence of the measured temperature and prior the deposits of energy produce an a priori estimate of the cool down period.